Seroatlas · Human Serome Atlas

AGPS

Alkyldihydroxyacetonephosphate synthase, peroxisomal

Also known as: ADAP-S, ADAS, ADAS_HUMAN, ADHAPS, ADPS, ALDHPSY

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O00116
Gene
AGPS
Ensembl
ENSG00000018510
Chromosome
2
Canonical length
658 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Subcellular location
Peroxisomes
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene is a member of the FAD-binding oxidoreductase/transferase type 4 family. It encodes a protein that catalyzes the second step of ether lipid biosynthesis in which acyl-dihydroxyacetonephosphate (DHAP) is converted to alkyl-DHAP by the addition of a long chain alcohol and the removal of a long-chain acid anion. The protein is localized to the inner aspect of the peroxisomal membrane and requires FAD as a cofactor. Mutations in this gene have been associated with rhizomelic chondrodysplasia punctata, type 3 and Zellweger syndrome. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

658 residues, UniProt reviewed canonical sequence.

>O00116|AGPS
     1  MAEAAAAAGG TGLGAGASYG SAADRDRDPD PDRAGRRLRV LSGHLLGRPR EALSTNECKA
    61  RRAASAATAA PTATPAAQES GTIPKKRQEV MKWNGWGYND SKFIFNKKGQ IELTGKRYPL
   121  SGMGLPTFKE WIQNTLGVNV EHKTTSKASL NPSDTPPSVV NEDFLHDLKE TNISYSQEAD
   181  DRVFRAHGHC LHEIFLLREG MFERIPDIVL WPTCHDDVVK IVNLACKYNL CIIPIGGGTS
   241  VSYGLMCPAD ETRTIISLDT SQMNRILWVD ENNLTAHVEA GITGQELERQ LKESGYCTGH
   301  EPDSLEFSTV GGWVSTRASG MKKNIYGNIE DLVVHIKMVT PRGIIEKSCQ GPRMSTGPDI
   361  HHFIMGSEGT LGVITEATIK IRPVPEYQKY GSVAFPNFEQ GVACLREIAK QRCAPASIRL
   421  MDNKQFQFGH ALKPQVSSIF TSFLDGLKKF YITKFKGFDP NQLSVATLLF EGDREKVLQH
   481  EKQVYDIAAK FGGLAAGEDN GQRGYLLTYV IAYIRDLALE YYVLGESFET SAPWDRVVDL
   541  CRNVKERITR ECKEKGVQFA PFSTCRVTQT YDAGACIYFY FAFNYRGISD PLTVFEQTEA
   601  AAREEILANG GSLSHHHGVG KLRKQWLKES ISDVGFGMLK SVKEYVDPNN IFGNRNLL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against AGPS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
21 nTPM

Expression across tissuesHPA

Tissue

  • rectum: 21 nTPM
  • smooth muscle: 20 nTPM
  • colon: 19 nTPM
  • bone marrow: 19 nTPM
  • liver: 18 nTPM
  • parathyroid gland: 17 nTPM

Single-cell type

  • hematopoietic stem cells: 1,042 nCPM
  • neutrophil progenitors: 517 nCPM
  • breast lactating cells: 286 nCPM
  • thymocytes: 281 nCPM
  • early spermatids: 252 nCPM
  • late primary spermatocytes: 242 nCPM

Immune cell

  • eosinophil: 5.8 nTPM
  • T-reg: 4.3 nTPM
  • intermediate monocyte: 4.1 nTPM
  • myeloid DC: 3.6 nTPM
  • non-classical monocyte: 3.6 nTPM
  • classical monocyte: 3.3 nTPM

Brain region

  • white matter: 31 nTPM
  • medulla oblongata: 25 nTPM
  • spinal cord: 22 nTPM
  • pons: 21 nTPM
  • cerebellum: 20 nTPM
  • midbrain: 20 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about AGPS.

Disease | AllUniProt

Conditions AGPS is implicated in, by any mechanism.

Disease | GeneticClinVar

30 pathogenic / likely-pathogenic of 815 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.12
gnomAD pLI
1
gnomAD missense Z
3.23
DepMap mean gene effect
-0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of AGPS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads AGPS as an antibody target. Whether an autoantibody or antibody against AGPS could matter depends on whether native AGPS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

AGPS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label AGPS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/AGPS. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...